Expanding biomarkers for PARP inhibitors
Nat Cancer
.
2022 Oct;3(10):1141-1143.
doi: 10.1038/s43018-022-00440-8.
Authors
Florence Coussy
1
,
Francois-Clement Bidard
2
3
4
Affiliations
1
Institut Curie, Department of Medical Oncology, Paris and Saint-Cloud, France.
2
Institut Curie, Department of Medical Oncology, Paris and Saint-Cloud, France. francois-clement.bidard@curie.fr.
3
Université Paris-Saclay, UVSQ, Saint-Cloud, France. francois-clement.bidard@curie.fr.
4
Inserm CIC-BT 1428, Paris, France. francois-clement.bidard@curie.fr.
PMID:
36253485
DOI:
10.1038/s43018-022-00440-8
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Agents* / pharmacology
Biomarkers
Phthalazines
Poly(ADP-ribose) Polymerase Inhibitors* / pharmacology
Substances
Poly(ADP-ribose) Polymerase Inhibitors
Phthalazines
Antineoplastic Agents
Biomarkers